...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Waiting for some great news about Zenith

The only great news would be a complete buyout of Zenith for a comparable valuation of what constellation pharma got. 

Share
New Message
Please login to post a reply